Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: License announcement PR improvement suggestion

I think it would help attract new investors if TPL/PTSC would include the number of companies that have been put on notice and the number of companies in negotiations on each new licensing PR.  I think these numbers would show potential investors that there is a lot more money coming in and highlights the potential of the MMP.

Just a thought

all the best,

Steve

Share
New Message
Please login to post a reply